Canada - Toronto Stock Exchange - TSX:CRRX - CA14173C1059 - Common Stock
The current stock price of CRRX.CA is 3.88 CAD. In the past month the price increased by 3.47%. In the past year, price increased by 73.21%.
ChartMill assigns a technical rating of 10 / 10 to CRRX.CA. When comparing the yearly performance of all stocks, CRRX.CA is one of the better performing stocks in the market, outperforming 75.72% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to CRRX.CA. While CRRX.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.03% | ||
| ROA | 0.04% | ||
| ROE | 0.11% | ||
| Debt/Equity | 0.85 |
12 analysts have analysed CRRX.CA and the average price target is 5.02 CAD. This implies a price increase of 29.25% is expected in the next year compared to the current price of 3.88.
For the next year, analysts expect an EPS growth of 202.73% and a revenue growth 1.2% for CRRX.CA
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PCRX.CA | PHARMACORP RX INC | N/A | 82.69M | ||
| WOLF.CA | GREY WOLF ANIMAL HEALTH CORP | 24 | 49.23M |
CareRx Corp. engages in the provision of pharmacy and other healthcare services. The company is headquartered in Toronto, Ontario and currently employs 1,423 full-time employees. The company went IPO on 2002-09-04. The firm serves approximately 88,000 residents in approximately 1,450 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company has a network of pharmacy fulfillment centers located across the country. The company supports its home care partners by providing solutions for the supply of chronic medication. The company uses technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimens. Revicare by CareRx is a distributor of medical supplies and continence care management products to residents in retirement and supportive living communities. The firm works with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.
CARERX CORP
320 Bay St. Suite 1200
TORONTO ONTARIO M4R 1K8 CA
CEO: David Murphy
Employees: 1423
Phone: 16473614499
CareRx Corp. engages in the provision of pharmacy and other healthcare services. The company is headquartered in Toronto, Ontario and currently employs 1,423 full-time employees. The company went IPO on 2002-09-04. The firm serves approximately 88,000 residents in approximately 1,450 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company has a network of pharmacy fulfillment centers located across the country. The company supports its home care partners by providing solutions for the supply of chronic medication. The company uses technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimens. Revicare by CareRx is a distributor of medical supplies and continence care management products to residents in retirement and supportive living communities. The firm works with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.
The current stock price of CRRX.CA is 3.88 CAD. The price increased by 1.04% in the last trading session.
CARERX CORP (CRRX.CA) has a dividend yield of 2.06%. The yearly dividend amount is currently 0.
CRRX.CA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CRRX.CA.
CARERX CORP (CRRX.CA) has a market capitalization of 243.63M CAD. This makes CRRX.CA a Micro Cap stock.
CARERX CORP (CRRX.CA) will report earnings on 2026-03-03, after the market close.